Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
ECG 10s (CHRIS baseline)
x0ec105l
P-Amplitude positive, V6
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec105f
P-Amplitude positive, aVF
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec105e
P-Amplitude positive, aVL
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec105d
P-Amplitude positive, aVR
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
Food frequency questionnaire (CHRIS baseline)
x0ff058
Peanuts
Peanuts
Categorical
Food frequency questionnaire (CHRIS baseline)
x0ff114
Pear
Pear
Categorical
Food frequency questionnaire (CHRIS baseline)
x0ff068
Peas
Peas
Categorical
Stress perception (CHRIS baseline)
x0pcver
PSS version
Perceived Stress Scale version
Categorical
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec07
Percentage of interval differences of successive NN intervals greater than 50 ms (pNN50)
Percentage of interval differences of successive NN intervals greater than 50 ms (pNN50)
Float
Person (CHRIS baseline)
x0pen1
Person notes (birth)
Person notes (birth)
Character
Person (CHRIS baseline)
x0pen3
Person notes (education)
Person notes (education)
Character
Person (CHRIS baseline)
x0pen2
Person notes (family)
Person notes (family)
Character
Person (CHRIS baseline)
x0pever
Person version
Person version
Categorical
Major psychiatric diagnoses (CHRIS baseline)
x0mp21
Personality disorder (affected by)
Personality disorder: Affected?
Categorical
Major psychiatric diagnoses (CHRIS baseline)
x0mp21b
Personality disorder (age at onset)
Personality disorder: Age at onset
Integer
Major psychiatric diagnoses (CHRIS baseline)
x0mp21a
Personality disorder (diagnosed)
Personality disorder: Diagnosed?
Categorical
Major psychiatric diagnoses (CHRIS baseline)
x0mp21c
Personality disorder (1st degree relative affected)
Personality disorder: Relatives affected?
Categorical
Movement disorder examination (CHRIS baseline)
x0md024
Pharmacological anamnesis Beta blockers
Pharmacological anamnesis Beta blockers
Boolean
Movement disorder examination (CHRIS baseline)
x0md024a
Pharmacological anamnesis Beta blockers (specify)
Pharmacological anamnesis Beta blockers (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md021
Pharmacological anamnesis Beta-agonists
Pharmacological anamnesis Beta-agonists
Boolean
Movement disorder examination (CHRIS baseline)
x0md021a
Pharmacological anamnesis Beta-agonists (specify)
Pharmacological anamnesis Beta-agonists (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md019a
Pharmacological anamnesis CCB (specify)
Pharmacological anamnesis CCB (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md019
Pharmacological anamnesis Calcium channel blockers (CCB)
Pharmacological anamnesis Calcium channel blockers (CCB)
Boolean
Movement disorder examination (CHRIS baseline)
x0md022
Pharmacological anamnesis Cortisonics
Pharmacological anamnesis Cortisonics
Boolean
Movement disorder examination (CHRIS baseline)
x0md022a
Pharmacological anamnesis Cortisonics (specify)
Pharmacological anamnesis Cortisonics (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md025
Pharmacological anamnesis Other
Pharmacological anamnesis Other
Boolean
Movement disorder examination (CHRIS baseline)
x0md025a
Pharmacological anamnesis Other (specify)
Pharmacological anamnesis Other (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md017a
Pharmacological anamnesis SSRI (specify)
Pharmacological anamnesis SSRI (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md017
Pharmacological anamnesis Selective serotonin reuptake inhibitor (SSRI)
Pharmacological anamnesis Selective serotonin reuptake inhibitor (SSRI)
Boolean
Movement disorder examination (CHRIS baseline)
x0md018a
Pharmacological anamnesis TCA (specify)
Pharmacological anamnesis TCA (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md020
Pharmacological anamnesis Theophylline
Pharmacological anamnesis Theophylline
Boolean
Movement disorder examination (CHRIS baseline)
x0md020a
Pharmacological anamnesis Theophylline (specify)
Pharmacological anamnesis Theophylline (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md023
Pharmacological anamnesis Thyroid hormones
Pharmacological anamnesis Thyroid hormones
Boolean
Movement disorder examination (CHRIS baseline)
x0md023a
Pharmacological anamnesis Thyroid hormones (specify)
Pharmacological anamnesis Thyroid hormones (specify)
Character
Movement disorder examination (CHRIS baseline)
x0md018
Pharmacological anamnesis Tricyclic antidepressants (TCA)
Pharmacological anamnesis Tricyclic antidepressants (TCA)
Boolean
Movement disorder examination (CHRIS baseline)
x0md016
Pharmacological anamnesis Typical / atypical neuroleptics
Pharmacological anamnesis Typical / atypical neuroleptics
Boolean
Movement disorder examination (CHRIS baseline)
x0md016a
Pharmacological anamnesis Typical / atypical neuroleptics (specify)
Pharmacological anamnesis Typical / atypical neuroleptics (specify)
Character
Drug intake (CHRIS baseline)
x0dd08
Pharmacological form
Pharmacological form (Pharma Form)
Character
Targeted serum metabolomics (CHRIS baseline)
x0pt022
Phe
Phenylalanine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt022a
Phe assay flags
Phenylalanine flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt124
PC ae C30:0
Phosphatidylcholine acyl-alkyl C30:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt124a
PC ae C30:0 assay flags
Phosphatidylcholine acyl-alkyl C30:0 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt125
PC ae C30:1
Phosphatidylcholine acyl-alkyl C30:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt125a
PC ae C30:1 assay flags
Phosphatidylcholine acyl-alkyl C30:1 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt126
PC ae C30:2
Phosphatidylcholine acyl-alkyl C30:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt126a
PC ae C30:2 assay flags
Phosphatidylcholine acyl-alkyl C30:2 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt127
PC ae C32:1
Phosphatidylcholine acyl-alkyl C32:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt127a
PC ae C32:1 assay flags
Phosphatidylcholine acyl-alkyl C32:1 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt128
PC ae C32:2
Phosphatidylcholine acyl-alkyl C32:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt128a
PC ae C32:2 assay flags
Phosphatidylcholine acyl-alkyl C32:2 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt129
PC ae C34:0
Phosphatidylcholine acyl-alkyl C34:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt129a
PC ae C34:0 assay flags
Phosphatidylcholine acyl-alkyl C34:0 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt130
PC ae C34:1
Phosphatidylcholine acyl-alkyl C34:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt130a
PC ae C34:1 assay flags
Phosphatidylcholine acyl-alkyl C34:1 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt131
PC ae C34:2
Phosphatidylcholine acyl-alkyl C34:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt131a
PC ae C34:2 assay flags
Phosphatidylcholine acyl-alkyl C34:2 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt132
PC ae C34:3
Phosphatidylcholine acyl-alkyl C34:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt132a
PC ae C34:3 assay flags
Phosphatidylcholine acyl-alkyl C34:3 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt133
PC ae C36:0
Phosphatidylcholine acyl-alkyl C36:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt133a
PC ae C36:0 assay flags
Phosphatidylcholine acyl-alkyl C36:0 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt134
PC ae C36:1
Phosphatidylcholine acyl-alkyl C36:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt134a
PC ae C36:1 assay flags
Phosphatidylcholine acyl-alkyl C36:1 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt135
PC ae C36:2
Phosphatidylcholine acyl-alkyl C36:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt135a
PC ae C36:2 assay flags
Phosphatidylcholine acyl-alkyl C36:2 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt136
PC ae C36:3
Phosphatidylcholine acyl-alkyl C36:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt136a
PC ae C36:3 assay flags
Phosphatidylcholine acyl-alkyl C36:3 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt137
PC ae C36:4
Phosphatidylcholine acyl-alkyl C36:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt137a
PC ae C36:4 assay flags
Phosphatidylcholine acyl-alkyl C36:4 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt138
PC ae C36:5
Phosphatidylcholine acyl-alkyl C36:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt138a
PC ae C36:5 assay flags
Phosphatidylcholine acyl-alkyl C36:5 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt139
PC ae C38:0
Phosphatidylcholine acyl-alkyl C38:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt139a
PC ae C38:0 assay flags
Phosphatidylcholine acyl-alkyl C38:0 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt140
PC ae C38:1
Phosphatidylcholine acyl-alkyl C38:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt140a
PC ae C38:1 assay flags
Phosphatidylcholine acyl-alkyl C38:1 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt141
PC ae C38:2
Phosphatidylcholine acyl-alkyl C38:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt141a
PC ae C38:2 assay flags
Phosphatidylcholine acyl-alkyl C38:2 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt142
PC ae C38:3
Phosphatidylcholine acyl-alkyl C38:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt142a
PC ae C38:3 assay flags
Phosphatidylcholine acyl-alkyl C38:3 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt143
PC ae C38:4
Phosphatidylcholine acyl-alkyl C38:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt143a
PC ae C38:4 assay flags
Phosphatidylcholine acyl-alkyl C38:4 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt144
PC ae C38:5
Phosphatidylcholine acyl-alkyl C38:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt144a
PC ae C38:5 assay flags
Phosphatidylcholine acyl-alkyl C38:5 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt145
PC ae C38:6
Phosphatidylcholine acyl-alkyl C38:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt145a
PC ae C38:6 assay flags
Phosphatidylcholine acyl-alkyl C38:6 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt146
PC ae C40:1
Phosphatidylcholine acyl-alkyl C40:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt146a
PC ae C40:1 assay flags
Phosphatidylcholine acyl-alkyl C40:1 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt147
PC ae C40:2
Phosphatidylcholine acyl-alkyl C40:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt147a
PC ae C40:2 assay flags
Phosphatidylcholine acyl-alkyl C40:2 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt148
PC ae C40:3
Phosphatidylcholine acyl-alkyl C40:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt148a
PC ae C40:3 assay flags
Phosphatidylcholine acyl-alkyl C40:3 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt149
PC ae C40:4
Phosphatidylcholine acyl-alkyl C40:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt149a
PC ae C40:4 assay flags
Phosphatidylcholine acyl-alkyl C40:4 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt150
PC ae C40:5
Phosphatidylcholine acyl-alkyl C40:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt150a
PC ae C40:5 assay flags
Phosphatidylcholine acyl-alkyl C40:5 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt151
PC ae C40:6
Phosphatidylcholine acyl-alkyl C40:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt151a
PC ae C40:6 assay flags
Phosphatidylcholine acyl-alkyl C40:6 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt152
PC ae C42:0
Phosphatidylcholine acyl-alkyl C42:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt152a
PC ae C42:0 assay flags
Phosphatidylcholine acyl-alkyl C42:0 flags
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt153
PC ae C42:1
Phosphatidylcholine acyl-alkyl C42:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt153a
PC ae C42:1 assay flags
Phosphatidylcholine acyl-alkyl C42:1 flags
Categorical
Previous
1
24
25
26
27
28
43
Next